E
Eun Young Mo
Researcher at Catholic University of Korea
Publications - 8
Citations - 110
Eun Young Mo is an academic researcher from Catholic University of Korea. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 5, co-authored 8 publications receiving 88 citations.
Papers
More filters
Journal ArticleDOI
Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.
TL;DR: Serum TB levels were inversely associated with diabetic peripheral neuropathy in Korean diabetic patients, and low serum bilirubin levels are significantly associated with DPN, independently of classic risk factors and other microvascular complications.
Journal ArticleDOI
Association between Lower Normal Free Thyroxine Concentrations and Obesity Phenotype in Healthy Euthyroid Subjects.
TL;DR: Low normal FT4 levels were independently related to IR in NW and OW/OB euthyroid subjects, and the association between low FT4 and IR remained significant in both NW andOW/OB subgroups.
Journal ArticleDOI
Inverse Association between Serum Bilirubin Levels and Arterial Stiffness in Korean Women with Type 2 Diabetes
TL;DR: Low TB levels were significantly associated with arterial stiffness in Korean women with type 2 diabetes and suggested that bilirubin may protect against macrovascular disease in diabetic women.
Journal ArticleDOI
Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population.
TL;DR: The association between NAFLD and serum calcium and phosphorus levels in Korean subjects is investigated and it is found that non‐alcoholic fatty liver disease is interrelated with renal dysfunction and disturbed bone metabolism.
Journal ArticleDOI
Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes.
Hye Eun Yoon,Hye Eun Yoon,Eun Young Mo,Seok Joon Shin,Seok Joon Shin,Sung Dae Moon,Je Ho Han,Eun Sook Kim +7 more
TL;DR: Serum GGT levels were significantly associated with obesity, atherogenic dyslipidaemia, and metabolic syndrome, but not with the early and late stages of atherosclerotic vascular changes, in patients with type 2 diabetes.